JPS649989A - Isoxazole compound - Google Patents

Isoxazole compound

Info

Publication number
JPS649989A
JPS649989A JP16465787A JP16465787A JPS649989A JP S649989 A JPS649989 A JP S649989A JP 16465787 A JP16465787 A JP 16465787A JP 16465787 A JP16465787 A JP 16465787A JP S649989 A JPS649989 A JP S649989A
Authority
JP
Japan
Prior art keywords
formula
compound expressed
rhodanin
chlorophenyl
expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16465787A
Other languages
Japanese (ja)
Inventor
Kazuo Ogawa
Ichiro Yamawaki
Yoichi Matsushita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP16465787A priority Critical patent/JPS649989A/en
Publication of JPS649989A publication Critical patent/JPS649989A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound expressed by formula I [R1 is pyridinyl (lower alkyl-substituted)cycloalkyl or formula II (R3 is H, halogen, acetoxy, OH or lower alkoxy); R2 is carboxyl or tetrazonyl]. EXAMPLE:5-{ 3-( 4-Chlorophenyl )-5-isoxazolylmethylene }-3-(5-tetraz-olylmethyl) rhodanin. USE:The compound expressed by formula I has excellent blood glucose lowering action, lipid lowering action and aldose reductase hindering action and is useful as a remedy for diabetes mellitus or diabetes complication. PREPARATION:An aldehyde derivative [e.g. 3-(4-chlorophenyl)isoxazole-5- aldehyde] expressed by formula III is subjected to condensation reaction with a rhodanin derivative [e.g. 3-(tetrazole-5-yl)methylrhodanin], preferably at a molar ratio of 1:1-1.2 at 20-200 deg.C to provide the compound expressed by formula I.
JP16465787A 1987-06-30 1987-06-30 Isoxazole compound Pending JPS649989A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16465787A JPS649989A (en) 1987-06-30 1987-06-30 Isoxazole compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16465787A JPS649989A (en) 1987-06-30 1987-06-30 Isoxazole compound

Publications (1)

Publication Number Publication Date
JPS649989A true JPS649989A (en) 1989-01-13

Family

ID=15797332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16465787A Pending JPS649989A (en) 1987-06-30 1987-06-30 Isoxazole compound

Country Status (1)

Country Link
JP (1) JPS649989A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159467A (en) * 1982-03-17 1983-09-21 Asahi Chem Ind Co Ltd Novel 3-substituted indazole derivative and its preparation
WO1991019496A1 (en) * 1988-09-13 1991-12-26 Tanabe Seiyaku Co., Ltd. Hypolipidemic agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159467A (en) * 1982-03-17 1983-09-21 Asahi Chem Ind Co Ltd Novel 3-substituted indazole derivative and its preparation
WO1991019496A1 (en) * 1988-09-13 1991-12-26 Tanabe Seiyaku Co., Ltd. Hypolipidemic agent

Similar Documents

Publication Publication Date Title
ID29931A (en) MODIFICATION OF CRYSTAL TORASEMIDES
JPS649989A (en) Isoxazole compound
CA1132584A (en) Halogen substituted benzopyran-and benzothiopyran-4-carboxylic acids
JP2876129B2 (en) 7-carboxymethoxy-4-phenylcoumarin derivatives and their preparation and use
JPS51136679A (en) Process for preparing 5-((2-halogeno-1-hydroxy) alkyl) carbostyril der ivatives
JPH05331161A (en) Chromone derivative and aldose reductase inhibitor containing the compound as an active ingredient
NO137198B (en) ANALOGICAL PROCEDURES FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVITIES, SUBSTITUTED XANTON CARBOXYLIC ACID COMPOUNDS
JPS55122785A (en) Preparation of benzopyranopyridine derivative
EP0092386B1 (en) Hydantoin therapeutic agents
JPS5683486A (en) Preparation of 1,3-benzodioxol-5-ol
JPS6456675A (en) Benzoxazole derivative
AU554303B2 (en) 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4- carboxylic acid
CA1076591A (en) Pharmaceutical compositions comprising substituted 3-cinnamoyl-2h-pyran-2,6(3h)-diones
JPS6471873A (en) Rhodanine compound
JPS5535003A (en) Preparation of aromatic aldehydes
JPS5527158A (en) 5-oxo-3,4,5,6,7,8-hexahydrocarbostyril derivative
JPS6438090A (en) Thiazolidine compound
JPH03184964A (en) Production of 4-formyl-1,2,3-thiadiazole
JPS6416779A (en) Dithioacetal derivative
JPS54151906A (en) Preparation of 1, 2, 3, 4-butane-tetracarboxylic acid
JPS56133286A (en) Benzoxazine derivative and its preparation
JPS6475473A (en) Production of hydantoin derivative
JPS554340A (en) Preparation of novel furan derivative
JPS5559170A (en) Novel 4-formyl-2-phenyl-1-phthalazone derivative
JPS57156432A (en) Preparation of anthraquinone